Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging

Area of Science:

• Cardiovascular Science
• Aging Research
• Mitochondrial Biology

Background:

• Cardiovascular aging involves progressive cellular and molecular changes, significantly linked to mitochondrial dysfunction.
• Understanding these mitochondrial alterations is key to preventing age-related cardiovascular diseases.

Purpose of the Study:

• To review the role of mitochondrial dysfunction in cardiac and vascular aging.
• To explore the impact of mitochondrial changes on fibrosis, metabolism, and immune responses in the aging heart.
• To highlight mitochondria-targeted therapies for preventing cardiovascular diseases in the elderly.

Main Methods:

• Literature review focusing on cardiovascular aging and mitochondrial function.
• Analysis of cellular and molecular alterations in cardiac and vascular aging.
• Synthesis of findings on fibrosis, metabolic remodeling, and immune responses.

Main Results:

• Mitochondrial dysfunction is central to cardiac aging, contributing to fibrosis, cardiomyocyte hypertrophy, metabolic shifts, and immune cell infiltration.
• Vascular aging is characterized by endothelial damage, increased stiffness, impaired angiogenesis, arteriosclerosis, and chronic inflammation, all influenced by mitochondrial health.
• The review consolidates evidence linking mitochondrial alterations to various aspects of cardiovascular aging.

Conclusions:

• Mitochondrial dysfunction is a critical factor in the pathogenesis of cardiovascular aging.
• Interventions targeting mitochondria hold promise for mitigating age-related cardiovascular decline.
• Further research into mitochondria-targeted therapies is essential for geriatric cardiovascular health.